Asthma Genetics in Filipino Mothers
In this CLHNS cohort, the findings support targeted replication of previously reported asthma signals in an understudied population, not discovery of new causal variants or clinical use of genetic results.
> Research explainer: This briefing examines verified primary research published 74 days before the briefing date. It is not a same-day research update and does not provide medical advice.
Asthma Genetics in Filipino Mothers
This research explainer examines a study published on 2026-06-18, 74 days before this briefing date. The investigators conducted the first genetic association study of asthma in a Filipino population, focusing on mothers in the Cebu Longitudinal Health and Nutrition Survey (CLHNS). [pmid:42316380]
Evidence
The analysis included 1,678 unrelated CLHNS mothers, of whom 129 reported asthma and 1,549 served as controls. Asthma status came from an affirmative response collected during the 2007 follow-up asking whether the mother had had asthma since 2002/2005 or the prior visit. [pmid:42316380]
Rather than scan the genome for previously unknown findings, the researchers used a candidate-variant design. They selected 27 asthma-associated single-nucleotide polymorphisms (SNPs), or suitable proxies, from Global Biobank Meta-Analysis Initiative (GBMI) multi-ancestry and East Asian asthma analyses. Individual associations were evaluated with logistic regression adjusted for age and 15 genetic-ancestry principal components. [pmid:42316380]
One tested signal passed the study’s Bonferroni-corrected threshold: rs17293632, an intronic variant in SMAD3. The reported odds ratio for self-reported asthma was 1.80, with a 95% confidence interval of 1.28 to 2.54 and P=0.0008. The study identifies SMAD3 as involved in TGF-β signalling related to airway remodelling in asthma. [pmid:42316380]
The authors also combined the tested variants into an East Asian GBMI-weighted genetic risk score. Each weighted-allele increase in that score was associated with higher odds of self-reported asthma, with an odds ratio of 1.07, a 95% confidence interval of 1.01 to 1.14, and P=0.022. [pmid:42316380]
A separate lookup examined 37 top signals from the GBMI East Asian asthma genome-wide association study. Five were associated in the CLHNS analysis, but none reached the Bonferroni threshold of P=1.35×10^-3 used for that lookup. [pmid:42316380]
Analysis — What the signal supports
The central result is best read as targeted evidence that a previously selected asthma-associated locus can be detected in this Filipino cohort, not as proof that the SMAD3 variant causes asthma. The study itself describes rs17293632 as an association, and its candidate-variant framework began with signals identified through larger GBMI analyses. [pmid:42316380]
The genetic risk score result adds a complementary population-level observation: when 27 selected variants were aggregated using effect-size weights from the GBMI East Asian analysis, the score was associated with asthma in CLHNS. This does not establish that a score determines an individual’s asthma status. It reports an association per weighted-allele increase within this study design and outcome definition. [pmid:42316380]
The study’s design also clarifies why the single SMAD3 finding and the risk-score finding should be considered together cautiously. Candidate testing concentrates statistical power on preselected variants, whereas a genome-wide association study would test across the genome. The authors state that the available sample was underpowered for a genome-wide association study and was therefore not designed to discover novel associations. [pmid:42316380]
The work contributes evidence from a population that the authors describe as previously lacking a Filipino asthma genetic association study. Its practical research implication is representation: testing known signals in additional populations can show whether findings from larger reference analyses are observable in a particular cohort. That implication remains distinct from causal inference, individual risk determination, diagnosis, treatment selection, or medical advice. [pmid:42316380]
Limitations
Asthma was self-reported rather than established here through an external clinical assessment, so outcome classification may not align perfectly with clinically confirmed asthma. [pmid:42316380]
The sample was limited to CLHNS mothers, with 129 self-reported asthma cases. This constrains statistical power and the extent to which the results can be generalized beyond this cohort. [pmid:42316380]
Only 27 preselected SNPs or proxies were tested. The approach is informative for evaluating selected known signals but does not provide a whole-genome search for additional associations. [pmid:42316380]
Finally, the reported odds ratios describe statistical associations in this analysis. They do not establish a causal pathway from rs17293632, SMAD3, or the genetic risk score to asthma. [pmid:42316380]